Biotech, Partnering

GSK biopharma partners for raxibacumab with BARDA

Posted on 20 September 2013

Tags: , , ,

GlaxoSmithKline , a big pharma company, announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services , for the provision of its inhalation anthrax treatment, raxibacumab, forming biopharma partners.

The US government is purchasing the medicine as a counter measure against a potential bioterrorist attack.

Under the terms of the new contract, GSK will provide 60,000 doses to the US government over four years, at a value of approximately $196m.

This forms part of a broader five year base contract for the biopharma partners.

Raxibacumab was approved by the FDA in December 2012 for the treatment of adult and pediatric patients with inhalation anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalation anthrax when alternative therapies are not available or are not appropriate.

For further deal information visit Current Agreements (subscription required)


Read: more on GSK company profile, recent partnering, M&A and financing news and articles

Report: Partnering Deals and Alliances with GlaxoSmithKline

Report: Monoclonal Antibodies Partnering Terms and Agreements

Related report: Partnering Deals and Alliances with Big Pharma

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View:Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View:Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup:Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe:Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply